MIRA SAFETY potassium iodide tablets

Dosing Instructions:

• Newborns (up to 1 month old) should receive ¼ tablet (16mg) per day
• Infants (between 1 month and three years) should receive ½ tablet (32mg) per day
• Children (between 3 and 18 years, up to 150lbs) should receive one tablet (65mg) per day
• Adults (age 18+) should receive two tablets per day

NOTE: Each dose lasts 24 hours. MIRA Safety recommends having at least a one-month supply for each family member. 

Radioactive iodine (I-131) is a significant component in the fallout produced by nuclear accidents, detonations, or reactor meltdowns.

Once ingested or inhaled, I-131 accumulates in the body’s thyroid gland—where it can cause mutation and, eventually, thyroid cancer. Potassium Iodide tablets are a proactive solution to protect yourself from I-131 by preventing absorption in the first place.

Tablets should be taken immediately upon finding out you’re at risk of potential exposure. Each dose provides 24 hours of protection, and each bottle contains 60 x 65mg tablets (dosing instructions below).

Since nearly two-thirds of Americans live within 50 miles of an active nuclear reactor, MIRA Safety recommends Potassium Iodide tablets for every household. Thyroid protection is vital for younger family members.

NOTE: The risk of developing thyroid cancer from I-131 exposure reduces with age, while the likelihood of experiencing side effects increases. Exercise caution if taking these supplements over the age of 40. 

• TSA APPROVED
• MILITARY